Navigation Links
California Stem Cell Agency Exaggerated Its Role in Funding Key Research
Date:4/16/2008

outlining the research findings was submitted to "Cancer Cell" on Sept. 19, 2007.

Read the notice of grant award here: http://www.consumerwatchdog.org/resources/Noticeofgrant.pdf

"CIRM is too eager to claim immediate results," said Simpson. "Certainly we'll see great benefit as the result of stem cell research, but this political manipulation and hype does a tremendous disservice to all who believe in the value of this research."

After Jensen asked questions about the CIRM release, the agency modified the version posted on its website to note that an earlier CIRM training grant had gone to pay the salary of a post doctoral researcher in Jamieson's laboratory.

"Stem cell agency officials repeatedly say, 'It's all about the science,'" said Simpson. "If only that were true. More often than not -- as in this case -- it's all about appearances, hype and claiming credit."

Proposition 71 that created CIRM passed by 59 percent of Californians voting in 2004. Consumer Watchdog's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will sell $3 billion in bonds over a decade to fund stem cell research. Financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

Consumer Watchdog, formerly the Foundation for Taxpayer and Consumer Rights, is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org.


'/>"/>
SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
2. New Conflict of Interest Violations Revealed at California Stem Cell Institute
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
5. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
6. Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
9. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
10. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
11. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Today, Hill-Rom Holdings, Inc. (NYSE: ... on significant strategic and financial initiatives at its ... Conference is hosted by Peter H. Soderberg, president ... on the following topics: ,, Status of ... development and financial updates Smart technologies that ...
(Date:12/15/2009)... Rib-X Pharmaceuticals, Inc., a company focused ... drugs for the treatment of serious multi-drug-resistant infections ... research agreement with Massachusetts General Hospital (MGH). ... collaboration, Dr. David Hooper of MGH will evaluate ... model to determine resistance development and to validate ...
(Date:12/15/2009)... SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 ... AMLN ), Eli Lilly and Company (NYSE: ... ALKS ) today announced positive results from ... investigational diabetes therapy, to BYETTA® (exenatide) injection taken ... After 24 weeks of treatment, patients taking exenatide ...
Breaking Medicine Technology:Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 1First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 2First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 3First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 4Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 1Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 2Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 3Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2
... /PRNewswire/ -- At the April AACR,Annual Meeting, Indivumed ... a new drug test-platform to predict drug,response in ... currently the first,choice for cancer drug testing. During ... protein expression patterns,change significantly, thereby losing many of ...
... 2007 - Insmed Inc.,(Nasdaq:INSM) today announced positive results ... drug, IPLEX(TM), in,patients with myotonic muscular dystrophy (DM1)., ... at,the University of Rochester School of Medicine and ... of IPLEX up to 1,mg/kg/day in six patients ...
Other Medicine Technology:Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4
(Date:12/15/2009)... require that certain businesses with large areas where people gather, ... available. Fire and rescue personnel agree that for any size ... , ... Issaquah, WA (PRWEB) December ... that certain businesses with large areas where people gather, need ...
(Date:12/15/2009)... SAN DIEGO, Dec. 15 "The entire San ... mourns the passing of Sol Price on December 14, ... standards of integrity, loyalty and ethics in his business, ... and thoughtful humanitarian who truly understood the responsibility of ... and his legacy will live on through his countless ...
(Date:12/15/2009)... UT Southwestern Medical Center researchers have provided ... unique observable characteristics seen in patients with an ... reported online and in the December issue of ... suggest that patients with atypical progeroid syndrome ... diagnosed with two similar but more well-defined accelerated ...
(Date:12/14/2009)... and synthetic red-blood-cell-like particles carry oxygen, drugs, and more… ... ... Scientists at UC Santa Barbara, in collaboration with scientists at ... the characteristics and key functions of natural red blood cells, ... , , , , ,The primary function of natural red ...
(Date:12/14/2009)... Fla., Dec. 14 Abbott (NYSE: ... definitive agreement to acquire STARLIMS Technologies Ltd. ... of laboratory information management systems, for approximately ... acquisition strengthens Abbott,s competitive position in the ... to help laboratories efficiently store, retrieve and ...
Breaking Medicine News(10 mins):Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4
... controls the rapid production and differentiation of the stem cells that ... open the door to more streamlined treatments for leukemia and other ... , ... (Vocus) April 8, 2009 -- Researchers have identified ...
... IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") participated ... at PLA 301 Hospital in Beijing on April 5, ... and Hong Kong attended the inaugural event that focused ... was opened by Dir Chen Xiaohong, Director of PLA ...
... Leadership Conference on April 24 ALEXANDRIA, Va., April 8 ... president and CEO, joined an invitation-only meeting at the ... appointed Director of the White House Office of Health ... to this important meeting is an indicator of the ...
... AJ,s grocery stores sell limited-edition, reusable grocery totes to ... age-old question of "paper or plastic" by choosing to ... Children,s Hospital. Bashas, Food City and AJ,s grocery stores ... Shamrock Farms on a charitable "green" mission this spring. ...
... drug lowers prostate specific antigen (PSA) levels a ... prostate cancer for whom traditional treatment options have failed. ... Center (MSKCC), is published today in Science ... ., Most men with metastatic prostate cancer eventually build ...
... Cancer Researchers and Updates on Key Discoveries, Plus ... April 8 Internationally renowned physician-scientists will discuss ... US, plus important recent discoveries in translational cancer ... Cancer Research Foundation Clinical Investigator Symposium.The ...
Other Medicine News:Health News:Scientists Identify Key Gene That Protects Against Leukemia 2Health News:Scientists Identify Key Gene That Protects Against Leukemia 3Health News:Scientists Identify Key Gene That Protects Against Leukemia 4Health News:Neurosurgeons from around the world gather at PLA 301 Hospital in China 2Health News:NHPCO President/CEO Meets with Nancy-Ann Min DeParle at White House 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 3Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 4Health News:Drug shows activity in men with advanced prostate cancer 2Health News:Drug shows activity in men with advanced prostate cancer 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 2Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 4
Enzyme Immunoassay of Protein C Antigenby ELISA Method, 96 tests...
Substrate Plasma for Factor II Assay by STA© Analyzers. Freeze-dried human serum and absorbed bovine plasma, the latter providing factor V and fibrinogen to the test system....
Substrate Plasma for Factor IX Assay by STA© Analyzers. Freeze-dried human plasma from which factor IX has been removed by selective immuno-adsorption....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Medicine Products: